Skip to content

Veracyte VCYT Return on equity

Return on equity at other companies

Guardant Health logo
Guardant HealthGH
-438.1%-1,655pp
Natera, Inc. logo
Natera, Inc.NTRA
-29%+4.1pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.5%+1.3pp
Revvity logo
RevvityRVTY
3.2%-0.5pp
Labcorp Holdings logo
Labcorp HoldingsLH
11.1%+2.1pp
Quest Diagnostics logo
Quest DiagnosticsDGX
14.3%+0.9pp

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.28B+10.7%
Enterprise value$4.05B+7.4%
P/E48.6×-68.3×
P/S7.9×-0.4×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Calculated from Veracyte’s reported figures.

Based on trailing twelve months.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's return on equity?
Veracyte (VCYT) reported return on equity of 6.9% in Q1 2026.
How has Veracyte's return on equity changed year-over-year?
Veracyte's return on equity increased by 142.6% year-over-year, from 2.9% to 6.9%.
What is the long-term trend for Veracyte's return on equity?
Over 5 years (2020 to 2025), Veracyte's return on equity has grown at a -12.8% compound annual growth rate (CAGR), from -10.6% to 5.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.